Table 1.
Overview of the main articles reporting the prevalence of MDR in the COVID area.
| Author, Year | Country | Type of Publication | No. Coinfections | No. MDR Coinfections | Microorganism (No.) | Death (No.) |
|---|---|---|---|---|---|---|
| Bogossian EG et al., 2020 | Belgium | Case control study | 72 | 31 | MDR Gram-negative (?): MDR Enterobacteriaceae (?) | 25 |
| Nori P. et al., 2021 |
USA | Retrospective observational study | 152 | 24 | MDR Gram-negative (24): carbapenem-resistant Enterobacteriaceae (10) | 15 |
| Ramadan HK et al., 2020 | Egypt | Case series | 28 | ? | MDR Gram-negative (?) | N/D |
| Patel A et al., 2021 |
USA | Retrospective observational study | 87 | 87 | MDR Gram-negative (?): MDR E. Coli (33), cefepime-resistant E. Coli (11), MDR P. aeruginosa (27), MDR A. baumannii (27) | N/D |
| Zhu X et al., 2020 |
China | Retrospective observational study | 243 | N/D | N/D | None |
N/D, no data.